Hologic (HOLX, Financial) continues to hold steady as investment firm Needham reiterates its "Hold" rating on the company's stock. This announcement was made by analyst Mike Matson on May 28, 2025, signaling a consistent position on the stock's performance.
Despite the reaffirmed rating, no current price target has been set for Hologic (HOLX, Financial) by Needham, maintaining its prior position without any change in price target expectations. The analysis aligns with previous assessments, reflecting a cautious approach towards Hologic's market position.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 15 analysts, the average target price for Hologic Inc (HOLX, Financial) is $66.94 with a high estimate of $72.12 and a low estimate of $60.00. The average target implies an upside of 7.67% from the current price of $62.17. More detailed estimate data can be found on the Hologic Inc (HOLX) Forecast page.
Based on the consensus recommendation from 22 brokerage firms, Hologic Inc's (HOLX, Financial) average brokerage recommendation is currently 2.7, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Hologic Inc (HOLX, Financial) in one year is $82.44, suggesting a upside of 32.6% from the current price of $62.17. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Hologic Inc (HOLX) Summary page.
